WuXi Biologics (Cayman) (FRA:1FW2) Days Payable

: 26.05 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

WuXi Biologics (Cayman)'s average Accounts Payable for the six months ended in Jun. 2023 was €91 Mil. WuXi Biologics (Cayman)'s Cost of Goods Sold for the six months ended in Jun. 2023 was €636 Mil. Hence, WuXi Biologics (Cayman)'s Days Payable for the six months ended in Jun. 2023 was 26.05.

The historical rank and industry rank for WuXi Biologics (Cayman)'s Days Payable or its related term are showing as below:

FRA:1FW2' s Days Payable Range Over the Past 10 Years
Min: 26.43 Med: 45.07 Max: 256.48
Current: 26.43

During the past 10 years, WuXi Biologics (Cayman)'s highest Days Payable was 256.48. The lowest was 26.43. And the median was 45.07.

FRA:1FW2's Days Payable is ranked worse than
85.85% of 714 companies
in the Biotechnology industry
Industry Median: 151.205 vs FRA:1FW2: 26.43

WuXi Biologics (Cayman)'s Days Payable declined from Jun. 2022 (38.56) to Jun. 2023 (26.05). It may suggest that WuXi Biologics (Cayman) accelerated paying its suppliers.

WuXi Biologics (Cayman) Days Payable Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

31.85

49.53

40.17

30.51

29.88

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial													30.36	38.56	35.20	26.05	24.37

Competitive Comparison

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman) Days Payable Distribution

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Days Payable distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Days Payable falls into.

WuXi Biologics (Cayman) Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

WuXi Biologics (Cayman)'s Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (85.84	+	107.564)	/	2 )	/	1156.984	*	365
=	96.702					/	1156.984	*	365
=	30.51

WuXi Biologics (Cayman)'s Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (107.564	+	73.877)	/	2 )	/	635.587	*	365 / 2
=	90.7205					/	635.587	*	365 / 2
=	26.05

WuXi Biologics (Cayman) Days Payable Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines